Highly Selective MMP-12 Antibodies

Researchers from the University of California, Riverside have developed potent monoclonal antibody inhibitors with high MMP-12 selectivity. These antibodies have applications in pharmaceuticals and biomedical sciences. Specifically, these antibodies may be developed as therapies for inflammatory and neurological diseases.

Fig 1: Inhibitory function of the MMP-12 antibodies LG4, LH6, and LH11 towards cdMMP-12.



Contact Information

Name: Grace Yee

Email: grace.yee@ucr.edu

Phone: 951-827-2212